BAYN Bayer Aktiengesellschaft

59.44USD54.08 EUR · XETRA-1.10%Mkt Cap: 59.05B USDP/E: —

Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates thro…

Institutional holders12 on file

Key Statistics

Company
Market Cap59.05B USD
Enterprise Value96.37B USD
Revenue (TTM)50.31B USD
Gross Profit29.43B USD
Net Income (TTM)-3.98B USD
Revenue/Share51.21 USD
Last Price59.44 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees87.8K
CountryDE
SectorHealthcare
IndustryDrug Manufacturers - General
ISINDE000BAY0017
Valuation
P/E (Trailing)—
P/E (Forward)11.28
PEG4.65
EV/EBITDA7.66
EV/Revenue1.92
P/S1.17
P/B1.84
EPS (TTM)-1.62 USD
EPS (Forward)5.33 USD
52W Range
29.2888% of range63.58
52W High63.58 USD
52W Low29.28 USD
Profitability
Gross Margin58.76%
Oper. Margin16.53%
EBITDA Margin25.02%
Profit Margin-7.94%
ROE-13.95%
ROA-3.46%
ROIC11.23%
ROCE8.53%
Growth
Revenue Growth4.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF6.52B USD
CapEx (TTM)2.73B USD
FCF Margin12.76%
FCF Yield10.87%
Net Debt33.88B USD
Net Debt/EBITDA2.69
Net Debt/FCF5.28
Balance Sheet
Debt/Equity1.40
Current Ratio1.35
Quick Ratio0.93
Book Value/Sh32.64 USD
Cash/Share14.10 USD
Dividends
Fwd Div Rate0.12 USD
Trail. Div Rate0.12 USD
Div. Yield0.20%
5Y Avg Yield0.62%
Payout Ratio162.16%
Ex-Div DateApr 27, 2026
Pay Date—
Analyst Consensus
Rating1.9 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)66.59 USD
Upside (mean)+12.0%
Target Range53.31 USD – 76.94 USD
53.31+12.0% to mean76.94
# Analysts18
Ownership
Shares Out.982.42M
Float982.42M
Insiders0.00%
Institutions62.79%
Technical
SMA 5053.72 (+10.7%)
SMA 20048.54 (+22.5%)
Beta0.81
S&P 52W Chg12.00%
Avg Vol (30d)2.60M
Avg Vol (10d)2.70M
Technical Indicators
RSI (14)61.3
MACD2.5128
MACD Signal2.4937
MACD Hist.+0.0192
BB Upper68.06 USD
BB Middle58.01 USD
BB Lower47.95 USD
BB Width34.67%
ATR (14)1.681 USD
Vol Ratio (20d)0.76x

About Bayer (ETR: BAYN)

›

Bayer (ETR: BAYN) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Drug Manufacturers - General industry, part of the Healthcare sector, and reports about 87,775 employees.

The shares were at 54.08 EUR on 20 November 2026, up 92.5% over 52 weeks. Its 52-week range is 26.64 EUR to 57.84 EUR: the price is 6.5% below the high and 103.0% above the low.

Its market capitalisation is 53.72B EUR. It pays a dividend yielding 0.20% (it pays out 162% of its earnings), against a median of 2.43% among the dividend payers in that peer group.

Bayer reports return on equity of -14.0%, an operating margin of 16.5% and revenue up 4.1% year over year.

Its debt exceeds its cash by 30.82B EUR, a debt-to-equity ratio of 1.40. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 18 analysts cover the stock, with an average rating of Buy; their mean price target of 60.58 EUR is 12.0% above the current price. The next earnings report is expected on 24 February 2027.